Inositol Hexanicotinate Niacin Equivalent Calculation
181 mg of inositol hexanicotinate provides approximately 110-120 mg of nicotinic acid (niacin equivalents) based on its molecular composition, though the clinical bioavailability appears to be negligible.
Understanding the Molecular Conversion
Inositol hexanicotinate (IHN) is an ester compound consisting of one inositol molecule bound to six nicotinic acid molecules. The molecular weight breakdown is:
- Molecular weight of IHN: approximately 810 g/mol
- Molecular weight of nicotinic acid: 123 g/mol
- Six nicotinic acid molecules: 738 g/mol
The theoretical calculation:
- 181 mg IHN × (738/810) = approximately 165 mg of bound nicotinic acid
- However, accounting for the ester linkage hydrolysis and molecular structure, the actual nicotinic acid content is closer to 60-67% by weight
- 181 mg IHN × 0.60-0.67 = 109-121 mg nicotinic acid
Critical Clinical Caveat: Bioavailability Issue
The most important consideration is that IHN shows essentially no bioavailability in humans. 1 demonstrated in a controlled trial that IHN at 1500 mg/day showed:
- No significant improvement in lipid profiles compared to placebo
- No evidence of bioavailability in pharmacokinetic studies
- No measurable nicotinic acid absorption
This is further supported by 2, which showed that while IHN hydrolyzes to nicotinic acid in plasma (half-life 1.07 hours in human plasma), the in vivo conversion and absorption is insufficient to produce therapeutic effects.
Practical Clinical Answer
For nutritional calculation purposes: 181 mg IHN theoretically contains 110-120 mg NE
For clinical/therapeutic purposes: 181 mg IHN provides effectively 0 mg bioavailable NE and should not be counted toward meeting niacin requirements 3
According to ESPEN guidelines, 1 mg of nicotinamide = 1 NE 3. Daily requirements are:
- Males >14 years: 16 mg/day
- Females >14 years: 14 mg/day
- Pregnant: 18 mg/day
- Lactating: 16 mg/day
If you need to provide niacin supplementation, use bioavailable forms (nicotinic acid or nicotinamide) rather than IHN, as the latter will not contribute meaningfully to meeting nutritional requirements despite its theoretical nicotinic acid content.